Preventing and Reversing Type 2 Diabetes in Michigan. A BCBSM Collaborative Quality Initiative
Type 2 diabetes is one of the most common, costly, and disabling diseases in the world. Approximately one million patients in Michigan have type 2 diabetes and rates are up to 2x higher for Michiganders who are Black, Latino, or have a disability. At the same time, the implementation of guideline concordant diabetes care lags behind due to challenges with coverage, lack of resources, cost of medications, and lack of support and education. Primary care practices continue to combat staffing issues, lack of resources, and increasing administrative demands. Meanwhile coordination of care for diabetes is confounded by an increasingly-complex healthcare system.
The Michigan Collaborative for Type 2 Diabetes (MCT2D) was established in 2021 to accelerate a new way forward, through collaboration, innovation, and investment in quality, evidence based care for type 2 diabetes. MCT2D strives to remove barriers to guideline concordant care, support participating practices, and keep patients central to quality improvement work.
Mission
MCT2D strives to prevent type 2 diabetes and its complications by fostering a collaborative community of clinicians and patients to accelerate the equitable implementation of evidence-based diabetes care for all patients in Michigan.
Vision
A world where Type 2 Diabetes is no longer a progressive disease.
Health Equity Vision
We envision a Michigan where all individuals have equitable access to the best care for type 2 diabetes regardless of race, ethnicity, socio-economic status, insurance coverage, or geographic location. Our collaborative efforts will lead to reduced prevalence and complications of type 2 diabetes and improved quality of life for every patient.
Bringing together primary care, endocrinology, nephrology, obesity medicine, pharmacy, dietetics, care management, and more to advance as a team.
Our Members
The Michigan Collaborative for Type 2 Diabetes is a coalition of over 1000 physicians, coming together from across 346 primary care, endocrinology, and nephrology practices, all of whom are represented by 28 physician organizations spanning the state.
Know exactly what you need to do next using our administrative portal.
Monitor your practices’ and physicians’ participation in real-time and never miss a VBR deadline with auto-reminders and customized check lists. Requires Member Login - Ask PO Lead for Access
Monthly learning events with continuing education and VBR credit. Workgroups and networking for the entire diabetes care team. Crowdsourced knowledge like our dot phrase library and best practice database. One-on-one consultations with MCT2D experts.
Dr. Oshman is a family physician and clinical associate professor in the University of Michigan Department of Family Medicine. Prior to joining the University of Michigan in 2020, she practiced for five years in Concord, New Hampshire, then served as a residency faculty member and vice-chair for quality at NorthShore University Health System in Chicago.
Dr. Diez is a clinical pharmacist specialist and clinical assistant professor in the University of Michigan College of Pharmacy. She graduated from the University of Michigan (UM) College of Pharmacy (2004) and completed a community practice residency at the University of Washington and Kelley Ross Pharmacy in Seattle, WA (2005).
Once per month we deliver news, updates, events, and more directly to you!
ccteam@mct2d.org
Support for The Michigan Collaborative for Type 2 Diabetes (MCT2D) is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program.
Although Blue Cross Blue Shield of Michigan and MCT2D work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs and viewpoints of BCBSM or any of its employees.